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The spliceosome is a huge molecular machine that
assembles dynamically onto its pre-mRNA substrates.
A new study based on interactome analysis provides
clues about how splicing-regulatory proteins modulate
assembly of the spliceosome to either activate or
repress splicing.Modeling the splicing interactomeIntroduction
Massive molecular machines comprising dozens to
hundreds of proteins, as well as RNA components,
catalyze transcription, RNA splicing and translation.
These machines vary substantially in their modes of
assembly and regulation. While ribosomes come preas-
sembled (in prokaryotes) or in just two pieces (eukary-
otes), the spliceosome that catalyzes removal of introns
from eukaryotic primary transcripts comprises several
pieces that must assemble de novo on each of its in-
tronic substrates. Once assembled, the spliceosome is
one of the largest complexes in the cell, comprising hun-
dreds of proteins linked by uncounted stable interac-
tions, as well as transient interactions that form as
rearrangements occur during splicing [1]. These pieces
include five small nuclear ribonucleoprotein particles
(snRNPs), each formed from a distinct small nuclear
RNA (snRNA) wrapped in a shell of proteins. These
snRNPs, as well as other proteins, comprise the catalytic
core of the spliceosome.
Dozens of protein factors can regulate splicing, me-
diating alternative splicing outcomes, such as exon
skipping, inclusion or intron retention, to produce
distinct mRNA and protein isoforms from a single
gene locus [1, 2]. These factors can be roughly
grouped into splicing activators, splicing repressors* Correspondence: cburge@mit.edu
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unless otherwise stated.and factors with more-variable activities, but the
mechanisms by which activation and repression occur
are still not well understood. Akerman and colleagues
[3] report the generation of a spliceosome-centric
interactome to identify specific features of splicing
activators and repressors that might help uncover
regulatory mechanisms.The major spliceosome, which is responsible for splicing
the vast majority of introns, contains approximately 150
to 300 proteins, depending on its stage of assembly and
other variables. Some of these proteins form highly
stable complexes, such as the rings formed by Sm
proteins, whereas others interact only transiently at spe-
cific stages of spliceosome assembly, making the splicing
interactome particularly complex.
In an effort to make sense of this complexity and to
understand the functions of splicing regulators, Akerman
and colleagues [3] build a probabilistic model of the pro-
tein–protein interactions (PPIs) among splicing factors
called the ‘probabilistic spliceosome’ (or PS-network)
(Fig. 1). They use the Human Protein Reference Database
(HPRD) as a source of data on interactions, which is based
mostly on large-scale yeast two-hybrid (Y2H) experi-
ments. Central to their analysis is the graph theory con-
cept of ‘transitivity’, or clustering coefficient, which
measures the extent to which a pair of nodes in a network
share interactions with other nodes. For example, Y2H
might have failed to detect an interaction between two
splicing factors ‘A’ and ‘B’ but successfully detected that
each interacts with several of the same spliceosomal pro-
teins, yielding a high transitivity score that enables the in-
ference that A and B are often in proximity and likely
interact. The authors also use gene-expression data, fol-
lowing the logic that interacting proteins should tend to
be coexpressed. The Y2H and expression data were com-
bined in a Bayesian approach to produce a composite
‘probability of interaction’ (Pin) for each pair of proteins,
and PS-networks were built from interactions pre-
dicted at each of several Pin cutoffs. These networksn Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
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Fig. 1 Representation of the interactomes of a prototypical splicing activator, SRSF1, and a prototypical splicing repressor, HNRNPA1. Akerman
and colleagues [3] report that activators — which promote exon inclusion (shown at right) — form more interactions with components of the
spliceosome than repressors, which promote exon exclusion (left). EJC exon junction complex; hnRNP heterogeneous nuclear ribonucleoprotein;
RBM RNA binding motif; SRSF serine/arginine-rich splicing factor
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interaction matrix screen of splicing factors that de-
tected over 600 interactions between approximately
200 proteins [4]. The results were promising, detecting
55 % of spliceosome interactions at a moderate thresh-
old (Pin ≥ 0.1) that retained a high prediction specificity
of 85 %.
The resulting PS-network identifies approximately ten
clusters of proteins based on similarity in interaction
profiles, using an approach similar to that of Ravasz and
colleagues [5]. Many of these clusters correspond to
established functional groupings of factors, with a clusterof U1/U2 snRNP factors, a cluster associated with
the Bact and C spliceosomal complexes, and a cluster
that included SR proteins and heterogeneous nuclear
ribonucleoproteins (hnRNPs). These clusters could
provide insights into the predominant stage of spli-
cing at which a particular factor acts. One could also
compare these data with those of clusters of splicing
factors identified by Papasaikas et al. [6], who used
an orthogonal, functional approach involving cluster-
ing based on similarity in the pattern of splicing
changes observed following depletion of spliceosomal
and splicing regulatory factors through RNA interference
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ings support the intuitive notion that interacting proteins
tend to function similarly in splicing regulation.
Implications for the regulation of splicing
Whether an intron is spliced ultimately comes down to
whether a catalytically active spliceosome is assembled
on it or not. Regulation of splicing can involve either
recruiting components of the splicing machinery to
particular locations or blocking their access, or it can
occur by modulating interactions between core splicing
components, such as snRNPs. The Akerman study
focuses on two canonical classes of splicing factors — SR
proteins and hnRNPs — both of which are widely
expressed and well conserved across metazoans. Most SR
proteins (serine/arginine-rich splicing factors SRSF1–
SRSF7) can activate inclusion of exons to which they bind
at sites known as exonic splicing enhancers, whereas
SRSF9–SRSF11 mostly act as splicing repressors. The
hnRNPs also include several factors that act mostly as ac-
tivators, and others such as hnRNPs A1 and A2B1 that
function primarily as repressors, based on a recent com-
prehensive genomic analysis of binding and regulation [7].
A number of studies have explored the mechanisms by
which activators and repressors function, supporting a
variety of models. These include models in which activa-
tors recruit snRNPs to nearby sites or promote exon-
bridging interactions between snRNPs, and models in
which repressors bind on both sides of and ‘loop out’
exons or inhibit interactions between snRNPs [8]. How-
ever, the detailed mechanisms involved in the regulation
of splicing remain poorly understood.
Akerman and colleagues observe that splicing activator
proteins and splicing repressors exhibit very different
patterns of interactions in the PS-network. Activators
such as SRSF1 have high predicted connectivity to mul-
tiple subsets of spliceosomal factors, whereas repressors
such as HNRNPA1 interact with fewer factors. For
example, SRSF1 was predicted to interact with compo-
nents of all five snRNPs, including with factors of the
core Sf3 family of U2 snRNP, whereas HNRNPA1 was
predicted to interact mostly with other hnRNP proteins.
Furthermore, the SRSF1 interactome included many
more direct and RNA-independent PPIs, whereas the
PPIs of HNRNPA1 were more often RNA dependent.
The authors followed up these observations by
performing immunoprecipitation-mass-spectrometry,
confirming many of the interactions identified by
the PS-network, including a novel interaction between
SRSF1 and specific Sf3a subunits. Direct interactions
between SRSF1 and the Sf3a complex support a recruit-
ment model, whereby SR proteins facilitate the assembly
of the U2 snRNP (or stabilize its binding) on the pre-
mRNA to which they are bound. Previous biochemicalexperiments have shown that SRSF1 is present in U2-
containing cellular fractions and stabilizes the U2 snRNP
on pre-mRNA in in vitro splicing assays [9].
A steric-hindrance model for hnRNP-mediated repres-
sion only requires that hnRNPs block the accessibility of
core splicing machinery to pre-mRNA. While hnRNPs
are not particularly bulky proteins, their known ability
to bind cooperatively and spread on or loop out pre-
mRNA molecules could help to explain how hnRNP
binding to relatively short sequence motifs with moder-
ate affinity can result in blockade of spliceosome assem-
bly [10]. Akerman and colleagues also identify direct
interactions between splicing activators and repressors
(e.g., SRSF1 with SRSF9 and SRSF10). Such interactions
might help to explain why canonical activators can
sometimes repress, and canonical repressors can some-
times activate.
Conclusions
An important question for future study is to characterize
the interactomes and understand regulation by the
dozens of other splicing regulators that are not SR pro-
teins or hnRNPs. These factors can often activate or re-
press splicing with similar frequency, usually in a
manner that depends on where they bind in relation to
the regulated exons, often described by an ‘RNA map’.
For example, several factors might activate exon inclu-
sion when bound downstream of the exon, but might re-
press splicing when bound upstream.
Ultimately, one hopes that our understanding of the
splicing interactome will be unified with our understand-
ing of the structures and regulatory functions of individual
factors and complexes in order to fully illuminate the
underlying mechanisms.
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